Publications
Found 8 results
Filters: Author is C.A. Clara [Clear All Filters]
“Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas”, vol. 11, pp. 332-339, 2012.
, Andreassi MG, Foffa I, Manfredi S, Botto N, et al. (2009). Mutation research/fundamental and molecular mechanisms of mutagenesis. Mutat. Res. 666: 57-63.
http://dx.doi.org/10.1016/j.mrfmmm.2009.04.003
PMid:19393248
Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatry 75 (Suppl 2): ii2-11.
http://dx.doi.org/10.1136/jnnp.2004.040337
PMid:50411
Curran JE, Lea RA, Rutherford S, Weinstein SR, et al. (2001). Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int. J. Cancer 95: 271-275.
http://dx.doi.org/10.1002/1097-0215(20010720)95:4<271::AID-IJC1046>3.0.CO;2-D
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, et al. (2001). High-resolution haplotype structure in the human genome. Nat. Genet. 29: 229-232.
http://dx.doi.org/10.1038/ng1001-229
PMid:11586305
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, et al. (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
http://dx.doi.org/10.1126/science.1069424
PMid:12029063
Griffin CS and Thacker J (2004). The role of homologous recombination repair in the formation of chromosome aberrations. Cytogenet. Genome Res. 104: 21-27.
http://dx.doi.org/10.1159/000077462
PMid:15162011
Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655.
http://dx.doi.org/10.1007/s00109-004-0565-9
PMid:15322700
Hirai M, Suzuki S, Hinokio Y, Yamada T, et al. (2005). WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 69: 287-292.
http://dx.doi.org/10.1016/j.diabres.2005.01.012
PMid:16098926
Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160.
http://dx.doi.org/10.1007/s11060-004-2747-2
PMid:15674475
Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845.
PMid:11309331
Jacobsen NR, Raaschou-Nielsen O, Nexo B, Wallin H, et al. (2004). XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 213: 67-72.
http://dx.doi.org/10.1016/j.canlet.2004.04.033
PMid:15312685
Jara L, Dubois K, Gaete D, de Mayo T, et al. (2010). Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res. Treat. 122: 813-822.
http://dx.doi.org/10.1007/s10549-009-0709-2
PMid:20054644
Jeffreys AJ, Kauppi L and Neumann R (2001). Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat. Genet. 29: 217-222.
http://dx.doi.org/10.1038/ng1001-217
PMid:11586303
Jiao L, Hassan MM, Bondy ML, Wolff RA, et al. (2008). XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am. J. Gastroenterol. 103: 360-367.
http://dx.doi.org/10.1111/j.1572-0241.2007.01615.x
PMid:17986315 PMCid:2268638
Kiuru A, Lindholm C, Heinavaara S, Ilus T, et al. (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J. Neurooncol. 88: 135-142.
http://dx.doi.org/10.1007/s11060-008-9556-y
PMid:18330515
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225.
PMid:11895036
Lee SA, Lee KM, Park SK, Choi JY, et al. (2007). Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res. Treat. 103: 71-76.
http://dx.doi.org/10.1007/s10549-006-9348-z
PMid:17063279
Lin RC, Wang XL and Morris BJ (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11: 802-808.
http://dx.doi.org/10.1038/oby.2003.111
PMid:12805402
Loizidou MA, Michael T, Neuhausen SL, Newbold RF, et al. (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 112: 575-579.
http://dx.doi.org/10.1007/s10549-007-9881-4
PMid:18188695
Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128.
http://dx.doi.org/10.1016/S1535-6108(02)00040-5
Matullo G, Palli D, Peluso M, Guarrera S, et al. (2001). XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32) P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22: 1437-1445.
http://dx.doi.org/10.1093/carcin/22.9.1437
PMid:11532866
McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642.
http://dx.doi.org/10.1227/00006123-199210000-00004
PMid:1407448
Miller RD and Kwok PY (2001). The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum. Mol. Genet. 10: 2195-2198.
http://dx.doi.org/10.1093/hmg/10.20.2195
PMid:11673401
Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202.
http://dx.doi.org/10.1080/00313029800169236
PMid:9643506
Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7.
http://dx.doi.org/10.1111/j.1440-1789.2004.00600.x
PMid:15822813
Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108.
http://dx.doi.org/10.1007/s00401-005-0991-y
PMid:15685439
Patil N, Berno AJ, Hinds DA, Barrett WA, et al. (2001). Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719-1723.
http://dx.doi.org/10.1126/science.1065573
PMid:11721056
Phillips MS, Lawrence R, Sachidanandam R, Morris AP, et al. (2003). Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat. Genet. 33: 382-387.
http://dx.doi.org/10.1038/ng1100
PMid:12590262
Reich DE, Cargill M, Bolk S, Ireland J, et al. (2001). Linkage disequilibrium in the human genome. Nature 411: 199-204.
http://dx.doi.org/10.1038/35075590
PMid:11346797
Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244.
http://dx.doi.org/10.1016/0360-3016(93)90203-8
Smith TR, Miller MS, Lohman K, Lange EM, et al. (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 190: 183-190.
http://dx.doi.org/10.1016/S0304-3835(02)00595-5
Sreeja L, Syamala VS, Syamala V, Hariharan S, et al. (2008). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 134: 645-652.
http://dx.doi.org/10.1007/s00432-007-0328-4
PMid:17952468
Tamura K, Suzuki M, Arakawa H, Tokuyama K, et al. (2003). Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int. Arch. Allergy Immunol. 131: 33-38.
http://dx.doi.org/10.1159/000070432
PMid:12759487
Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, et al. (1995). Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl. Acad. Sci. U. S. A. 92: 6354-6358.
http://dx.doi.org/10.1073/pnas.92.14.6354
Thacker J (2005). The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219: 125-135.
http://dx.doi.org/10.1016/j.canlet.2004.08.018
PMid:15723711
Winsey SL, Haldar NA, Marsh HP, Bunce M, et al. (2000). A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 60: 5612-5616.
PMid:11059748
Yamada Y, Ando F, Niino N and Shimokata H (2003). Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J. Clin. Endocrinol. Metab. 88: 3372-3378.
http://dx.doi.org/10.1210/jc.2002-021449
Zhou K, Liu Y, Zhang H, Liu H, et al. (2009). XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int. J. Cancer 124: 2948-2953.
http://dx.doi.org/10.1002/ijc.24307
PMid:19330829
“Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas”, vol. 10, pp. 1120-1129, 2011.
, Au WW, Salama SA and Sierra-Torres CH (2003). Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 111: 1843-1850.
doi:10.1289/ehp.6632
PMid:14630517 PMCid:1241747
Caldecott KW (2003). XRCC1 and DNA strand break repair. DNA Repair 2: 955-969.
doi:10.1016/S1568-7864(03)00118-6
Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatr. 75 (Suppl 2): ii2-11.
doi:10.1136/jnnp.2004.040337
PMid:50411
Curran JE, Lea RA, Rutherford S, Weinstein SR, et al. (2001). Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int. J. Cancer 95: 271-275.
doi:10.1002/1097-0215(20010720)95:4<271::AID-IJC1046>3.0.CO;2-D
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, et al. (2001). High-resolution haplotype structure in the human genome. Nat. Genet. 29: 229-232.
doi:10.1038/ng1001-229
PMid:11586305
Felini MJ, Olshan AF, Schroeder JC, North KE, et al. (2007). DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29: 55-58.
doi:10.1159/000108919
PMid:17898525
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, et al. (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
doi:10.1126/science.1069424
PMid:12029063
Goode EL, Ulrich CM and Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 11: 1513-1530.
PMid:12496039
Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655.
doi:10.1007/s00109-004-0565-9
PMid:15322700
Hirai M, Suzuki S, Hinokio Y, Yamada T, et al. (2005). WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 69: 287-292.
doi:10.1016/j.diabres.2005.01.012
PMid:16098926
Hu Z, Ma H, Chen F, Wei Q, et al. (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomark. Prev. 14: 1810-1818.
doi:10.1158/1055-9965.EPI-04-0793
Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160.
doi:10.1007/s11060-004-2747-2
PMid:15674475
Improta G, Sgambato A, Bianchino G, Zupa A, et al. (2008). Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res. 28: 2941-2946.
PMid:19031937
Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845.
PMid:11309331
Jeffreys AJ, Kauppi L and Neumann R (2001). Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat. Genet. 29: 217-222.
doi:10.1038/ng1001-217
PMid:11586303
Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, et al. (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J. Appl. Genet. 51: 343-352.
doi:10.1007/BF03208865
PMid:20720310
Kawabata M, Kawabata T and Nishibori M (2005). Role of recA/RAD51 family proteins in mammals. Acta Med. Okayama 59: 1-9.
PMid:15902993
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225.
PMid:11895036
Ladiges WC (2006). Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene 25: 1612-1619.
doi:10.1038/sj.onc.1209370
PMid:16550161
Li H, Ha TC and Tai BC (2009). XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 18: 183-191.
doi:10.1016/j.breast.2009.03.008
PMid:19446452
Lin RC, Wang XL, Dalziel B, Caterson ID, et al. (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11: 802-808.
doi:10.1038/oby.2003.111
PMid:12805402
Loizidou MA, Michael T, Neuhausen SL, Newbold RF, et al. (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 112: 575-579.
doi:10.1007/s10549-007-9881-4
PMid:18188695
Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128.
doi:10.1016/S1535-6108(02)00040-5
McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642.
doi:10.1227/00006123-199210000-00004
PMid:1407448
Miller RD and Kwok PY (2001). The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum. Mol. Genet. 10: 2195-2198.
doi:10.1093/hmg/10.20.2195
PMid:11673401
Moullan N, Cox DG, Angele S, Romestaing P, et al. (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomark. Prev. 12: 1168-1174.
PMid:14652276
Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202.
doi:10.1080/00313029800169236
PMid:9643506
Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7.
doi:10.1111/j.1440-1789.2004.00600.x
PMid:15822813
Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108.
doi:10.1007/s00401-005-0991-y
PMid:15685439
Patil N, Berno AJ, Hinds DA, Barrett WA, et al. (2001). Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719-1723.
doi:10.1126/science.1065573
PMid:11721056
Phillips MS, Lawrence R, Sachidanandam R, Morris AP, et al. (2003). Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat. Genet. 33: 382-387.
doi:10.1038/ng1100
PMid:12590262
Reich DE, Cargill M, Bolk S, Ireland J, et al. (2001). Linkage disequilibrium in the human genome. Nature 411: 199-204.
doi:10.1038/35075590
PMid:11346797
Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244.
doi:10.1016/0360-3016(93)90203-8
Sreeja L, Syamala VS, Syamala V, Hariharan S, et al. (2007). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 134: 645-652.
doi:10.1007/s00432-007-0328-4
PMid:17952468
Sturgis EM, Castillo EJ, Li L, Zheng R, et al. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129.
doi:10.1093/carcin/20.11.2125
PMid:10545415
Tae K, Lee HS, Park BJ, Park CW, et al. (2004). Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int. J. Cancer 111: 805-808.
doi:10.1002/ijc.20338
PMid:15252855
Tamura K, Suzuki M, Arakawa H, Tokuyama K, et al. (2003). Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int. Arch. Allergy Immunol. 131: 33-38.
doi:10.1159/000070432
PMid:12759487
Wang LE, Bondy ML, Shen H, El-Zein R, et al. (2004). Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 64: 5560-5563.
doi:10.1158/0008-5472.CAN-03-2181
PMid:15313891
Wang N, Dong XJ, Zhou RM, Guo W, et al. (2009). An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol. Biol. Rep. 36: 357-364.
doi:10.1007/s11033-007-9187-y
PMid:18046624
Yamada Y, Ando F, Niino N and Shimokata H (2003). Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J. Clin. Endocrinol. Metab. 88: 3372-3378.
doi:10.1210/jc.2002-021449
“GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas”, vol. 9, pp. 2328-2334, 2010.
, Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatry 75 (Suppl 2): ii2-ii11.
http://dx.doi.org/10.1136/jnnp.2004.040337
PMid:15146033 PMCid:1765661
De Roos AJ, Rothman N, Inskip PD, Linet MS, et al. (2003). Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol. Biomarkers Prev. 12: 14-22.
PMid:12540498
Ezer R, Alonso M, Pereira E, Kim M, et al. (2002). Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J. Neurooncol. 59: 123-134.
http://dx.doi.org/10.1023/A:1019601305210
PMid:12241105
Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655.
http://dx.doi.org/10.1007/s00109-004-0565-9
PMid:15322700
Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160.
http://dx.doi.org/10.1007/s11060-004-2747-2
PMid:15674475
Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845.
PMid:11309331
Kabesch M, Hoefler C, Carr D, Leupold W, et al. (2004). Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax 59: 569-573.
http://dx.doi.org/10.1136/thx.2003.016667
PMid:15223862 PMCid:1747082
Kadouri L, Kote-Jarai Z, Hubert A, Baras M, et al. (2008). Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br. J. Cancer 98: 2006-2010.
http://dx.doi.org/10.1038/sj.bjc.6604394
PMid:18542066 PMCid:2441947
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225.
PMid:11895036
Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128.
http://dx.doi.org/10.1016/S1535-6108(02)00040-5
McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642.
http://dx.doi.org/10.1227/00006123-199210000-00004
PMid:1407448
McLeish S and Turner SW (2007). Gene-environment interactions in asthma. Arch. Dis. Child 92: 1032-1035.
http://dx.doi.org/10.1136/adc.2006.112185
PMid:17954484 PMCid:2083615
Millikan R, Pittman G, Tse CK, Savitz DA, et al. (2000). Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol. Biomarkers Prev. 9: 567-573.
PMid:10868690
Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202.
http://dx.doi.org/10.1080/00313029800169236
PMid:9643506
Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7.
http://dx.doi.org/10.1111/j.1440-1789.2004.00600.x
PMid:15822813
Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108.
http://dx.doi.org/10.1007/s00401-005-0991-y
PMid:15685439
Okcu MF, Selvan M, Wang LE, Stout L, et al. (2004). Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin. Cancer Res. 10: 2618-2625.
http://dx.doi.org/10.1158/1078-0432.CCR-03-0053
PMid:15102663
Reszka E, Wasowicz W and Gromadzinska J (2007). Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case-control study. Genes Nutr. 2: 287-294.
http://dx.doi.org/10.1007/s12263-007-0057-y
PMid:18850183 PMCid:2474940
Ryberg D, Skaug V, Hewer A, Phillips DH, et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289.
http://dx.doi.org/10.1093/carcin/18.7.1285
PMid:9230269
Saxena A, Dhillon VS, Raish M, Asim M, et al. (2009). Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res. Treat. 115: 537-543.
http://dx.doi.org/10.1007/s10549-008-0098-y
PMid:18574688
Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, et al. (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol. Biomarkers Prev. 16: 559-565.
http://dx.doi.org/10.1158/1055-9965.EPI-06-0918
PMid:17372252
Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244.
http://dx.doi.org/10.1016/0360-3016(93)90203-8
Singh M, Shah PP, Singh AP, Ruwali M, et al. (2008). Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat. Res. 638: 184-194.
http://dx.doi.org/10.1016/j.mrfmmm.2007.10.003
PMid:18035380
Syamala VS, Sreeja L, Syamala V, Raveendran PB, et al. (2008). Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam. Cancer 7: 213-220.
http://dx.doi.org/10.1007/s10689-007-9177-1
PMid:18080216
White DL, Li D, Nurgalieva Z and El-Serag HB (2008). Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am. J. Epidemiol. 167: 377-389.
http://dx.doi.org/10.1093/aje/kwm315
PMid:18065725
Wideroff L, Vaughan TL, Farin FM, Gammon MD, et al. (2007). GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect. Prev. 31: 233-236.
http://dx.doi.org/10.1016/j.cdp.2007.03.004
PMid:17646057 PMCid:2268246
Ye Z, Song H, Higgins JP, Pharoah P, et al. (2006). Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 3: e91.
http://dx.doi.org/10.1371/journal.pmed.0030091
PMid:16509765 PMCid:1391981
“Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma”, vol. 8, pp. 1257-1263, 2009.
, “Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors”, vol. 8, pp. 8-18, 2009.
, “Mutational analysis of genes p14ARF, p15INK4b, p16INK4a, and PTEN in human nervous system tumors”, vol. 7, pp. 451-459, 2008.
, , “Mutation analysis of gene PAX6 in human gliomas”, vol. 6, pp. 1019-1025, 2007.
,